540
Participants
Start Date
February 15, 2025
Primary Completion Date
November 10, 2025
Study Completion Date
October 10, 2027
Recombinant Herpes Zoster Vaccine (SCTV04C) Low-Dose
Route of vaccination: intramuscular injection into the lateral deltoid of the upper arm; Immunization procedure: 2 doses, 60 days apart;
Recombinant Herpes Zoster Vaccine (SCTV04C) High-Dose
Route of vaccination: intramuscular injection into the lateral deltoid of the upper arm; Immunization procedure: 2 doses, 60 days apart;
Placebo control: Saline
The placebo in this study is 0.9% sodium chloride (normal saline) injection; Immunization procedure: 2 doses, 60 days apart;
Shingrix®
Route of vaccination: intramuscular injection into the lateral deltoid of the upper arm; Dosage of vaccination: 50 μg; Immunization procedure: 2 doses, 60 days apart
Ganwei®
Route of vaccination: subcutaneous injection into the lateral deltoid of the upper arm; Dosage of vaccination: 0.5 mL; Immunization procedure: saline will be administered at Day 0, and Ganwei® will be administered at Day 60；
Dazhu CDC, Dazhou
Sinocelltech Ltd.
INDUSTRY